Skip to main content
Phreesia, Inc. (PHR)
NYSE: PHR · Real-Time Price · USD
25.38
+0.22 (0.87%)
Dec 23, 2024, 2:23 PM EST - Market open

Phreesia Revenue

Phreesia had revenue of $106.80M in the quarter ending October 31, 2024, with 16.57% growth. This brings the company's revenue in the last twelve months to $405.14M, up 19.91% year-over-year. In the fiscal year ending January 31, 2024, Phreesia had annual revenue of $356.30M with 26.84% growth.

Revenue (ttm)
$405.14M
Revenue Growth
+19.91%
P/S Ratio
3.54
Revenue / Employee
$281,736
Employees
1,438
Market Cap
1.48B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Jan 31, 2024356.30M75.39M26.84%
Jan 31, 2023280.91M67.68M31.74%
Jan 31, 2022213.23M64.56M43.42%
Jan 31, 2021148.68M23.89M19.15%
Jan 31, 2020124.78M24.90M24.92%
Jan 31, 2019 Pro Pro Pro
Jan 31, 2018 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Indivior 1.18B
Evotec SE 866.67M
AtriCure 447.57M
InMode 423.75M
Kiniksa Pharmaceuticals International, 384.10M
Immunocore Holdings 296.31M
Arcus Biosciences 263.00M
Travere Therapeutics 203.45M
Revenue Rankings

PHR News

More News